Paloma Partners Management Co Increases Stake in Envision Healthcare Corporation (EVHC)
Paloma Partners Management Co increased its stake in Envision Healthcare Corporation (NYSE:EVHC) by 37.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,514 shares of the company’s stock after buying an additional 2,328 shares during the period. Paloma Partners Management Co’s holdings in Envision Healthcare Corporation were worth $522,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Envision Healthcare Corporation during the first quarter valued at $135,000. Korea Investment CORP bought a new stake in Envision Healthcare Corporation during the first quarter valued at $141,000. Ameritas Investment Partners Inc. bought a new stake in Envision Healthcare Corporation during the first quarter valued at $172,000. First Interstate Bank bought a new stake in Envision Healthcare Corporation during the first quarter valued at $184,000. Finally, Daiwa Securities Group Inc. increased its stake in Envision Healthcare Corporation by 60.9% in the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after buying an additional 1,200 shares in the last quarter.
Shares of Envision Healthcare Corporation (EVHC) opened at 61.65 on Tuesday. Envision Healthcare Corporation has a 12-month low of $53.12 and a 12-month high of $80.01. The stock’s market capitalization is $7.16 billion. The stock has a 50 day moving average of $57.27 and a 200 day moving average of $62.64.
Envision Healthcare Corporation (NYSE:EVHC) last announced its earnings results on Tuesday, May 2nd. The company reported $0.69 EPS for the quarter, meeting analysts’ consensus estimates of $0.69. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $2.52 billion. Envision Healthcare Corporation had a negative net margin of 9.16% and a positive return on equity of 5.75%. Equities research analysts anticipate that Envision Healthcare Corporation will post $1.40 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/07/18/paloma-partners-management-co-increases-stake-in-envision-healthcare-corporation-evhc.html.
EVHC has been the topic of several research analyst reports. Jefferies Group LLC set a $75.00 target price on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Friday, April 21st. Canaccord Genuity reissued a “buy” rating and set a $86.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, April 18th. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 target price on shares of Envision Healthcare Corporation in a research report on Thursday, April 6th. Royal Bank Of Canada reissued a “buy” rating and set a $72.00 target price on shares of Envision Healthcare Corporation in a research report on Monday, June 5th. Finally, Zacks Investment Research raised shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 target price on the stock in a research report on Tuesday, July 4th. Three research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $67.80.
In other news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $60.00, for a total value of $90,000.00. Following the transaction, the insider now directly owns 99,363 shares of the company’s stock, valued at approximately $5,961,780. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold a total of 4,500 shares of company stock worth $274,830 over the last ninety days. Corporate insiders own 3.10% of the company’s stock.
Envision Healthcare Corporation Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.